PS10 A novel framework for the diagnosis, management and terminology of ‘dermatitis artefacta’
Rhiannon Nancarrow-Lei,Susannah Baron,Rukshana Ali,Tess McPherson
DOI: https://doi.org/10.1093/bjd/ljae090.381
IF: 11.113
2024-06-28
British Journal of Dermatology
Abstract:Abstract ‘Dermatitis artefacta’ (DA), or ‘factitious skin disorder’, was first documented in 1909 by Spanish dermatologist Juan de Azúa, known for confronting and challenging his patients {Heras-Mendaza F. [Dermatitis artefacta 100 years ago]. Actas Dermosifiliogr 2009; 100: 657–60 (in Spanish)}. This condition is recognized as challenging, and patients can present a significant burden on health services (Mohandas P, Ravenscroft JC, Bewley A. Dermatitis artefacta in childhood and adolescence: a spectrum of disease. G Ital Dermatol Venereol 2018; 153: 525–34). Although current practice emphasizes understanding ‘why not how’, communications with patients, families and health professionals expose problematic inconsistencies not only across different specialities but also among dermatology colleagues. Specifically, the terms ‘DA’, ‘artefactual’, ‘factious’ and ‘malingering’ carry negative connotations of secrecy, dismissal and judgement. They serve to medicalize the condition, excluding the patient and thereby hindering open and honest communication. It further misrepresents the condition as intentional ‘self-harm’, failing to recognize the hidden underlying psychological distress – a perspective that warrants reconsideration. We present a case series of 10 presentations in children and young people, which highlights specific themes to aid a positive diagnosis and demonstrates a novel way to communicate with successful outcomes. We advocate for a comprehensive rebranding of this condition. It should be considered a functional illness – a physical response to emotional distress and deeper psychological need that may not be readily apparent. The field of psychiatry has witnessed a shift towards less stigmatizing terminology, illustrated by the adoption of ‘dissociative seizures’ in lieu of ‘pseudoseizures’. Particularly within the paediatric patient group, a dissociative phenomenon is likely at play, leading to genuine distress observed when new lesions emerge. The method by which these lesions appear may remain a mystery to both the patient and their families. A positive diagnosis should be made, and communication should prioritize openness, honesty and a patient-centred approach. We propose the term ‘external skin lesions (ESLs)’. ‘ESL’ is more readily accepted and understood by patients and their families than ‘DA’. Rather than focusing on investigating ‘ESL’ methods, attention should be directed towards exploring the underlying psychological causes – triggers, stressors, anxiety, and aspects of home and school life. Reassurance is crucial, providing clarity that this recognized condition arises from external damage, frequently occurring unconsciously as an expression of anxiety, stress or upset. The reassurance should extend to the understanding that there is no concern regarding skin healing, and improvement is likely through collaborative efforts involving family, school, and healthcare teams.
dermatology